Note: The latest report on the criminal trials in Italy charging asbestos billionaire with causing deaths of Eternit employees and people in the surrounding communities by longtime Casale resident and journalist Silvana Mossano must be seen in the backdrop of the hearing in the three trial courts of these cases in which Schmidheiny, the asbestos billionaire has been convicted and sentenced him to various jail terms, all of which are being appealed to the Court of Appeal and then the Court of Cassation.
A lawyer well familiar with these matters reacted with shock to the delay by the Court of Cassation in sending the Naples case back for further litigation, possibly dooming the case to dismissal under the statute of limitations for manslaughter. The statute of limitations 'clock' keeps running, under the law in Italy, even after guilty verdicts have been issued by the trial and appeal courts. The legal expert said the Court of Cassation's refusal to decide the case now appears corrupt.
Dr. Barry Castleman, the author of "Asbestos: Medical and Legal Aspects"
ETERNIT BIS – The delicate issue of the causal link, expert witnesses return to court: Silvana Mossano
Mr Schmidheiny, your own defence team and expert witnesses recognise that asbestos fibres cause mesothelioma, but they blame those who came before you for spreading them and say that the tragic fate of the 392 victims listed in the trial (but there are many more!) cannot be attributed to the time when you were the head/owner of Eternit. The question is: if the fibres that were in circulation before you were deadly, can you really believe that the asbestos that was in circulation between 1976 and 1986 had no effect at all? That it didn't cause illnesses? The legal arguments are left to your defence team, the scientific ones to your expert witnesses. Ethics, on the other hand, is your responsibility: can you possibly rule out that the asbestos circulating in the air in ‘your’ decade caused an indefinite number of victims even if you don't know their names? There is, morally, a way to make amends, Mr Schmidheiny: find the cure.
Having reached the final stages of the Eternit Bis trial, before the Court of Assize of Appeal in Turin, closing statements focused on three crucial issues: the position (posizione di garanzia) of the defendant Stephan Schmidheiny (i.e. whether he was the effective head in charge of Eternit), the subjective element (i.e. whether he acted with malice or with guilt, whether or not he was aware) and the causal link (i.e. the correlation between the deaths from mesothelioma of the 392 victims listed in the charge and the spread of asbestos fibres that occurred in the decade 1976-1986, when Schmidheiny was the boss). The defendant is charged with the voluntary manslaughter (with eventual intent) of all these people.
SUMMARY
@ The role of science in court and the causal link
@ The prosecutor's expert witness
@ The defence's expert witness
@ Epidemiology in sentencing
@ From epidemiology to individual cases
@ Upcoming hearings
@ Cavagnolo and Napoli Trials
THE ROLE OF SCIENCE IN COURT
The third issue – the causal link – is essential. The court will have to adopt one a position and issue the verdict (expected on March the 19th ), but will have to motivate it after having evaluated the causal relationship on a case-by-case basis.
It is a delicate and complex trial that essentially relies on scientific pillars to be combined with legal criteria. Even more than in the Eternit One case for crime of environmental disaster, science has entered the courtroom with a central pivot.
After listening to the first part of the arguments presented by the prosecutor, the civil parties and the defence, and after reviewing the impressive number of expert reports, studies and judgements, the Court of Assizes of Appeal required further investigation.
THE PROSECUTOR'S EXPERT WITNESS
At the hearing on Monday 17 February, the prosecutor called Prof Corrado Magnani, a doctor, epidemiologist, researcher and author of numerous studies; he is qualified as one of the two authors who, worldwide, have had the highest number of studies published (the other was Dr Dario Mirabelli, also a prosecutor's expert witness in the Eternit trials, who died prematurely a couple of weeks ago).
On Monday, Professor Benedetto Terracini, former director of the Reference Centre for Epidemiology and Oncological Prevention in Piedmont (CROEP), was in the audience. He was the ‘Teacher’ of that group of Piedmontese researchers (including Magnani and Mirabelli) who initiated numerous epidemiological studies related to asbestos exposure.
Professor Corrado Magnani, expert witness for the public prosecutor
Dr Cristina Domaneschi, Chief Justice, and the Court listened to Prof Magnani, and then to the defence expert, Prof Canzio Romano. Dr Gino Barbieri, the expert witness for the plaintiffs, was also present and agreed with Prof Magnani's presentation. He had already submitted his report to the court, as had Dr Bai, also for the plaintiffs.
The causal link is a complex and thorny issue, so the presiding judge made a special recommendation: ‘We are not experts in medicine or statistics. We kindly ask you to adapt your language to our ability to understand’.
Professor Benedetto Terracini (on the right, wearing a blue pullover) in conversation with the PPs, on Monday during a break in the trial. At the back of the photo, consultants Prof Corrado Magnani and Dr Gino Barbieri
And that's what the scientist did: for four hours, standing up, as if he had returned to his university classroom in front of students, he endeavoured to respond to the Court's requests for clarification, balancing the appropriate scientific language - without oversimplifying it -.
‘We are asking for clarification on the so-called accelerator effect,’ Dr Domaneschi began. ’We are interested in the comparison between two groups of subjects who contract the disease: those who at a certain point ceased exposure and those who continued to be exposed.’
One should remember that ‘all the cases of mesothelioma considered in this trial are caused by exposure to asbestos: this is a certainty’ emphasised Magnani. Then we consider the intensity and duration of exposure, and the effects in terms of a shorter life expectancy.
The professor explained that ‘people suffering from mesothelioma die earlier than the general population’.
A group of Afeva activists at the Eternit trial.
How can we interpret the differences between two groups of subjects who have different degrees of exposure?
Prof Magnani presented some graphs that represent a Cartesian plane. On the horizontal x-axis is indicated the latency period (from the beginning of exposure to diagnosis) and on the vertical y-axis is marked the frequency of the disease.
‘In the group with greater exposure, the frequency of mesothelioma is higher, and the cases begin to appear earlier than in the less exposed group. This is the anticipation of the disease": it means, in essence, that “with less exposure to asbestos, those deaths would not have occurred or would have occurred later”. Prof Magnani referred to a large cohort study he coordinated, carried out after the National Conference on Asbestos in 2012. ‘We included 50,000 people who worked in 43 Italian companies, half of them in about twenty companies in the asbestos-cement sector. Three groups were formed, based on the amount of cumulative exposure.’ What was the outcome? ’In the group with intermediate exposure, deaths from mesothelioma occurred less frequently and at a later stage than in the group with the highest exposure.’ Similarly for the comparison between groups with ‘minimal’ and ‘highest’ exposure’. The study was published in an authoritative scientific journal and, years later, has not been the subject of contrary observations, therefore maintaining the approval of the international scientific community.
Prof Magnani quantified the reduction in life expectancy as fifteen to twenty years.
Regarding the shorter life expectancy, the prosecutor's expert witness also illustrated an important study conducted on laboratory mice, published in 2024. ‘The genetic heritage of the mice was altered so that they were destined to die of pleural mesothelioma. Then, the mice were divided into two groups: one was also given asbestos, the other was not. When the survival rate was compared, it was seen that the mice in the group exposed to asbestos became ill and died starting 90 days after the beginning of the experiment, compared to 170 days in the group subjected only to genetic manipulation. Conclusion: the addition of asbestos brings forward the onset of the disease. At autopsy, it was found that the mesotheliomas were more extensive in the mice exposed to asbestos.
Court's question: ‘Can a longer duration of exposure produce a greater accelerating effect?’
Prof Magnani cited a study conducted on workers in the sector. ‘The people who had a lower acceleration had worked in the company for less time or in departments less polluted by asbestos. Those who, on the other hand, had a greater cumulative exposure to the fibres, in terms of intensity and duration, had a greater acceleration’. To say that “if the workers had changed job or department earlier, they would have suffered less from the accelerating effect”. Among other things, continuous and additional exposure inhibits one of the defence mechanisms that our body uses to remove fibres, through macrophages, i.e. the ‘scavenger cells’ responsible for absorbing the ‘garbage’ that we somehow ingest.
Another issue on which the Court requested clarification is the so-called ‘preclinical phase’.
This is the time between when the disease has already irreversibly taken hold in the organism and does not require further external (exogenous) carcinogenic stimuli (i.e. stimuli from external agents such as asbestos) and the moment of diagnosis. In this phase, with the diagnostic tools available today, mesothelioma is not yet recognisable. It is only a question of understanding when it will reach a size at which it can be diagnosed. Professor Magnani reported studies that estimate the duration of the ‘preclinical phase’ to be between 9 and 11 years; in general, it is agreed and agreed upon that the average duration is ten years.
To the Court's precise question: ‘Is the ten-year period recognised by the scientific community?’ Professor Magnani's answer was: ‘Yes’.
Dissenting voices? ‘One study - Greengard O. et. al., 1987 - that quantifies this phase as 22 years. However, it is a study that has shown many limitations in materials and methods’ so much so that, in almost forty years, it has not been replicated. What does this mean? That the number of citations in subsequent studies is an indication of the authority of the published work: the higher the number, the more the study is worthy of consideration, and vice versa.
The president of the court also asked why it is important for science to establish the duration of the preclinical phase. The prosecutor's consultant explained that, in addition to the medical-legal interest, it can be of considerable importance, for example, for preventive purposes: ‘If mesothelioma could be diagnosed earlier, therapeutic strategies could be identified and anticipated as is the case for other forms of cancer’. Another topic: the risk of exposure in relation to distance from the source, which the consultants identified in the Eternit production plant in Ronzone (to be clear: one kilometre away from the Duomo, i.e. the heart of the city). How many kilometres away from the source are we at risk? Professor Magnani explains: ‘The distribution of fibres does not seem to reach more than eight or nine kilometres from the source, as the crow flies, but we must take into account that a person does not stay in one place, they move from one place to another, they even change residence’.
Then, to complicate and aggravate the environmental context of Casale there was the dust factor, widely used everywhere: ‘A widespread use that makes your skin crawl!’
The prosecutor's consultant recalled the story of a young woman born in 1976 who died of mesothelioma. From her personal file it emerged that ‘as a child she often went to play where there was a lot of dust. But if her parents had known what a serious danger it was, would they have let her go and play there?’ The professor realises he has overstepped the scientific mark, but he couldn't help himself: ‘Sorry, this isn't my subject, but behind every researcher there's a man too!’ As for the distribution of the dust (containing the terrible blue asbestos or crocidolite) used in and around the city for so-called ‘improper uses’ (insulation of attics and levelling of courtyards, playing fields, roads, etc.), the defence insisted that, when Schmidheiny arrived, a ban had been imposed. Why? ‘Because he knew it was highly carcinogenic. Deadly,’ the prosecutor observed. Yes, Schmidheiny knew. “He knew everything.” But then, faced with this precise awareness, what did the defendant do? The prosecutor was indignant: ’He did not warn the population, nor the public and health authorities, to share his knowledge and warn them. He said nothing, on the contrary he engaged in a massive propaganda campaign of mystification about the use of asbestos.
THE DEFENCE
The defence expert witness, Prof Canzio Romano queried Professor Magnani's arguments and reiterated his arguments already set out in a robust and detailed report.
Professor Canzio Romano, defence expert witness (Photo Archivio Silmos)
The main points: ‘Malignant mesothelioma is still a disease characterised by large grey areas that depend on the specific characteristics of this disease’. One of these grey areas, Prof Romano pointed out, is ‘the very long time between the exposure and the onset of the clinical manifestation of the tumour. The median latency, according to the mesothelioma (Renam) Registry, is 48 years’. Latency is the time between the beginning of exposure and diagnosis. Furthermore, ‘mesothelioma is described as a very aggressive tumour and, from this statement, one would deduce that it grows particularly quickly. But, if it is true that once the tumour has manifested itself clinically the survival rate is very low (even if it has increased a little), this could depend not on the natural aggressiveness of cell development, but on the fact that, by the time it is diagnosed, the mesothelioma is already very extensive and invasive’. Professor Romano, however, considers this a mere hypothesis, because, ‘in reality, we can say that we know nothing about the time it takes for this tumour to develop from the first altered cell until diagnosis’. The defence consultant insisted that ‘it is a neoplasm with large areas of uncertainty’. For example, ‘two apparently contrasting phenomena coexist: on the one hand, low levels or even short periods of exposure are sufficient for the disease to develop; on the other hand, as exposure increases, so does the risk. In my opinion, this means that how asbestos acts is largely unknown today’. He therefore maintains that ‘it is not possible to construct a plausible biological model’.
However, there are epidemiological studies. ‘It's not that epidemiological investigations are useless for individuals’, he concedes, ‘but they are useful in terms of policies and preventive regulations, not for the specific case’ he insists. ‘Epidemiology provides statistical results’ which, in the opinion of the defence counsel, “cannot be used in terms of causality for the individual”. In other words, he is convinced that epidemiological results cannot explain, “beyond any reasonable doubt”, when and how that subject became ill in the face of a certain exposure, with certain characteristics of intensity and duration. He reiterates: ‘We should understand if the subjects affected by mesothelioma developed the pathology earlier than it would have happened if Eternit had not been active between 1976 and 1986’, that is, the time when the defendant was the responsible manager. ‘The question has no answers because, in his opinion, “there are no answers. Magnani answered on logical, not factual grounds”. ‘To argue that all cases are anticipated and that the duration of the anticipation is the same for everyone is a hypothesis that has no biological or even epidemiological support’ was Professor Romano's inflexible conclusion.
EPIDEMIOLOGY IN JUDGMENT
The Court of Assizes of Novara has already had to face this question. In the grounds for the sentence, which fill over a thousand pages, it ruled as follows: ‘In the absence of a universal law of coverage, which would allow all events of a certain type to be traced back to a specific cause (a very rare eventuality), it is necessary to resort to a law of statistical coverage, according to which certain events can be related to specific causal antecedents with a high degree of probability’. Having made this premise, the judges of Novara, in considering ‘correctly usable the models deriving from statistical laws such as epidemiological ones’, affirmed that ‘one cannot simply apply the data to individual cases’, but ‘due attention must be paid to the presence of biological information which, synergistically with the statistical data, can explain that causal relationship that epidemiology itself has deduced from the probabilistic relationship’.
FROM EPIDEMIOLOGY TO INDIVIDUAL CASES
And Professor Magnani highlighted and confirmed that in the reports prepared by the consultants and delivered to the judges, the indications provided by the epidemiological studies were scrupulously applied to individual cases, taking into account, for each one, the circumstances of exposure to asbestos that characterised the lives and habits of those lives; moreover, and were confirmed, in the end, in the manifestation and evolution of the pathology described in the medical records. The result of this work is contained in the respective 392 files. These 392 files tell the story of 392 lives cut short, the names and surnames of men and women who lost fifteen or twenty years of loved ones, relationships, hopes, roles, falls and rises. A vital ribbon ruthlessly severed by invisible fibres that should not have circulated in such a reckless and illicit manner.
Court and Popular Judges (Jury)
UPCOMING HEARINGS
On Wednesday 26 February, from 11 a.m., the closing statements will be made by the for the prosecution (Dr Sara Panelli, prosecutor for the Attorney General's Office, Dr Gianfranco Colace and Dr Mariagiovanna Compare, prosecutors for the Turin and Vercelli Public Prosecutor's Offices). On Wednesday 5 and Wednesday 19 March, from 9 a.m., the Court will hear the closing statements of the defence lawyers Astolfo Di Amato and Guido Carlo Alleva. The verdict of the Court of Assizes of Appeal, i.e. the reading of the sentence, is expected on that the day, while the reasons for the verdict will be filed later.
THE CAVAGNOLO AND NAPOLI CASES
Meanwhile, the hearing in the Court of Cassation for the Eternit Bis case in Cavagnolo has been set for 21 March. The defendant Schmidheiny has already been convicted in the first and second degree for manslaughter: 1 year and 8 months, for the death, due to asbestosis, of a worker. The appeal sentence had already reached the Court of Cassation that had ordered a postponement, requesting more precise reasons on the issue of the causal link. The second Court of Appeal of Turin integrated it with further legal-scientific arguments.
The same happened for the Eternit Bis case in Naples. Stephan Schmidheiny had been sentenced to 3 and a half years for manslaughter, found guilty of a death by mesothelioma. The statute of limitations had instead been triggered for six cases, and he had been acquitted for one. On Wednesday 19th February, the Court of Cassation quashed the verdict and ordered a referral to the Court of Appeal on the same issue of the causal link.
Written by longtime Casale resident and journalist Silvana Mossano, translated by Vicky Franzinetti
https://www.silmos.it/eternit-bis-la-delicata-questione-del-nodo-causale-gli-scienziati-tornano-in-aula/
P.S.: Ban Asbestos Network of India (BANI) has documented that in India, Eternit was originally known as Asbestos Cement Ltd. when it was founded in 1934 in Maharashtra. In 1983, the company changed its name to Everest Building Product Ltd. and went public on the Bombay Stock Exchange.
The order dated December 23, 1994 by K. Sankararaman, Member, Customs, Excise and Gold Tribunal-Delhi recorded that "the name of the appellant company has been changed from M/s. Everest Building Products Ltd. to M/s. Eternit Everest Limited. The fresh certificate of incorporation consequent on change of name issued by the Addl. Registrar of Companies, Maharashtra, Bombay confirming the change of name of Everest Building Products Ltd. to Eternit Everest Limited was submitted along with the application. We accordingly allow the application. The cause title of the appeal should accordingly be changed to read M/s. Eternit Everest Limited instead of Everest Building Products Ltd.. The company registered and incorporated in India and engaged in the manufacture and sale of asbestos cement products." Madras High Court's order dated 25 June 25, 1996 by Justice D. Raju has recorded that Eternit Everest Ltd is "in the business of manufacture and sale of asbestos cement products for the last more than 50 years and carrying on their manufacturing activities at four factories situated at Kymore in Madhya Pradesh, Mulund in Bombay, Podanur in Tamil Nadu and Calcutta in West Bengal."
Notably, Indian government lowered import duties for asbestos by 68% during 1995-2000, giving asbestos imports a decided advantage over polyvinyl alcohol (PVA) fibers, whose duties are at about the levels that asbestos was in 1995. This was one reason because of which attempts by (Belgium’s) Etex affiliate Eternit Everest to replace asbestos in corrugated roofing with PVA failed in 2001.
ETEX sold its subsidiary to an Indian company in 2001, shortly before asbestos production was completely banned in Belgium.
Significantly, the company had converted a plant in Maharashtra and announced plans to do likewise with 3 other plants, making PVA-cement roofing and flat cement sheets using coir fiber. But in recent months, Etex’s 52% share in Eternit Everest was bought out by ACC, a large cement firm that had previously owned a 26% share. The Maharashtra plant was reconverted to use asbestos.
In 2003, the company took its current name, Everest Industries Limited. The subsidiaries of the former British company Turner and Newall PLC and the Belgium company ETEX (Eternit) dumped asbestos waste on 600,000 square metres of land on or near which more than 3000 people currently live in Kymore, Madhya Pradesh. The Kymore based factory is currently owned by Everest Industries Limited. It is situated in Vijayraghavgarh tehsil in Katni district in central Madhya Pradesh, Kymore has population of around 20,000 people. An environmental report by a Canadian company, ECOH found that there was one million tonnes of asbestos-contaminated surface soil in two different sites around the factory; at some places there was 70% asbestos concentration in the soil. Its estimate suggested that it is likely to cost at least $52 million to remediate the site.
At present, Everest Industries Limited has 5 manufacturing units at Kymore (Madhya Pradesh), Kolkata (West Bengal), Podanur (Tamil Nadu), Lakhmapur (Maharashtra) & Bhagawanpur (Uttarakhand). The unit at Podanur (Near Coimbatore) which is popularly known as Podanur works was established in the year 1953. Podanur works is roughly 10 km Coimbatore Coimbatore Town and it is in-between the road connecting Coimbatore and Pollachi. The site is located in the eastern direction of this road. The nearest railway station is Podanur. It's manufacturing process of fibre cement product is based on classical wet Hatschek process where in the Chrysotile Asbestos Fibre, Pulp is mixed with Portland Cement and Fly Ash in aqueous condition. The raw materials that are used in the manufacture of asbestos cement products are Chrysotile Asbestos Fibre, Ordinary Portland Cement, Fly ash, Pulp & Hard Ground Waste of broken and solid wastes. The entire Chrysotile Asbestos Fibre requirement is imported and received in ships at Cochin Port.